Video/ Infection Control

'Superbug' fungus emerging in N.Y. region

Two of the three kinds of commonly used antifungal drugs have little effect


The "superbug" fungus, Candida auris, is emerging as a new menace in U.S. hospitals, mostly in New York and New Jersey, according to an article and video on the AP website.
 
Two of the three kinds of commonly used antifungal drugs have little effect on C. auris
 
Infections related to the fungas tend to be diagnosed in patients after they've been in hospitals for several weeks. The fungus can infect wounds, ears and the bloodstream.
 
A recent study found the fungus on surfaces in hospital rooms and on the skin of nurses and patients — even after patients were treated with antifungal medications.
 
 



May 5, 2017


Topic Area: Infection Control


Recent Posts

Alleged Ransomware Administrator Extradited from South Korea

The Phobos ransomware has been used globally to target over 1,000 organizations, including healthcare.


Design Plans Unveiled for New Intermountain St. Vincent Regional Hospital

The new hospital will be a 14-floor, 737,000 square-foot facility in Billings, Montana.


Ground Broken on New Pediatric Health Campus in Dallas

The new campus will replace the existing Children’s Medical Center Dallas.


Pre-Construction Strategies for Successful Facilities Projects

Savvy decisions can help facilities meet long-term goals by creating consistency and eliminating waste.


Geisinger Finds Success with Violence Prevention Efforts

Their safety measures included training staff in de-escalation, active-shooter response drills and equipping 6,000 employees with duress notification badges.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.